Tri Locum Partners’s Exact Sciences EXAS Stock Holding History

Tri Locum Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-90,000	Closed	-$6.22M	–	31
2024 Q1	$6.22M	Buy	+90,000	New	+$5.69M	2.16%	18

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Tri Locum Partners's EXAS Position: Q2 2024 in Review

Tri Locum Partners sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 90,000 shares — an estimated $6.22M sold.

Tri Locum Partners first reported a position in EXAS in Q1 2024 and held it in 1 quarter. The position peaked at $6.22M in Q1 2024. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

Tri Locum Partners reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
Tri Locum Partners sold 90,000 Exact Sciences shares in Q2 2024, an estimated $6.22M.
Tri Locum Partners first reported a position in Exact Sciences in Q1 2024 and held it in 1 quarter.
Tri Locum Partners's Exact Sciences position peaked at $6.22M in Q1 2024.
542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Tri Locum Partners's 13F filing for Q2 2024, filed 14 Aug 2024.